Prohost has just finished a very hard task; evaluating its best picks from the biotechnology and biopharmaceutical sectors. In this evaluation of hand-selected stocks, Prohost did not consider the negotiation between the U.S. and China a serious factor that could affect the biotech stocks’ values. We do, however, consider the US/China negotiations extremely important towards reaching a fair solution that satisfies the people in both the United States and China.  

We never considered the possibility that a peaceful fair negotiation could escalate into a war that threatens to crash the market today, Monday, August 5, 2019 . . .